Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of innovative drugs to treat inflammatory conditions. There platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of novel mechanism of action therapies to safely and effectively treat inflammatory diseases.


Type
Public
HQ
Cambridge, US
Founded
2008
Size (employees)
38 (est)
Catabasis Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US
Report incorrect company information

Catabasis Pharmaceuticals Office Locations

Catabasis Pharmaceuticals has an office in Cambridge
Cambridge, US (HQ)
One Kendall Square Binney St, Bldg. 1400E, Suite B14202
Show all (1)
Report incorrect company information

Catabasis Pharmaceuticals Financials and Metrics

Catabasis Pharmaceuticals Financials

USD

Net income (Q1, 2018)

(7.7 m)

EBIT (Q1, 2018)

(7.6 m)

Market capitalization (22-Jun-2018)

26.4 m

Closing share price (22-Jun-2018)

0.9

Cash (31-Mar-2018)

17 m
Catabasis Pharmaceuticals's current market capitalization is $26.4 m.
Annual
USDFY, 2015FY, 2016

General and administrative expense

8.6 m10.1 m

R&D expense

23 m25.5 m

Operating expense total

31.7 m35.6 m

EBIT

(31.7 m)(35.6 m)
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

General and administrative expense

2.8 m2.6 m2.3 m2.4 m2.4 m2.4 m

R&D expense

6.4 m6.8 m5.9 m5.4 m4.5 m5.2 m

Operating expense total

9.2 m9.4 m8.3 m7.8 m6.9 m7.6 m

EBIT

(9.2 m)(9.4 m)(8.3 m)(7.8 m)(6.9 m)(7.6 m)
Annual
USDFY, 2015FY, 2016

Cash

62.8 m23.6 m

Inventories

804 k1 m

Current Assets

63.6 m39.5 m

PP&E

504 k568 k
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

23.8 m24.3 m26.5 m31.8 m29.4 m17 m

Current Assets

53.4 m43.7 m48.3 m32.8 m30.3 m17.9 m

PP&E

770 k718 k641 k494 k442 k258 k

Total Assets

54.3 m44.6 m48.9 m33.4 m30.8 m18.3 m
Annual
USDFY, 2015FY, 2016

Net Income

(32.6 m)(36.1 m)

Depreciation and Amortization

202 k395 k

Inventories

(450 k)(229 k)

Accounts Payable

196 k77 k
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(9.4 m)(9.4 m)(8.4 m)(7.9 m)(7.7 m)

Depreciation and Amortization

62 k

Accounts Payable

2.5 m1.8 m1.6 m1.6 m1.7 m942 k342 k

Cash From Operating Activities

(6.8 m)
USDY, 2018

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information

Catabasis Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information